Shock presents as an acute syndrome stemming from cardiovascular dysfunction and the circulatory system's incapacity to furnish adequate oxygen and nutrients, failing to meet the metabolic requirements of vital organs. The triad of fever, tachycardia, and tachypnea is common in benign infections among children. ¹ The suspicion of septic shock arises when these symptoms are accompanied by additional indicators such as altered mental state, prolonged capillary refill exceeding 2 seconds (indicative of cold shock), rapid capillary refill (indicative of warm shock), weakened or bounding peripheral pulses, or urinary output reduced to less than 1 ml/kg/hr. Hypotension, a sign of advanced septic shock, emerges relatively later in the progression. ^{1 , 2}

Septic shock often presents an array of coagulation irregularities, with the gravest form being disseminated intravascular coagulation (DIC). The genesis of DIC entails a complex interplay encompassing proinflammatory cytokines, factors that promote and inhibit coagulation, as well as dysfunction of the endothelium. While the exact prevalence of coagulation dysfunction associated with sepsis and DIC in children remains uncertain, approximations indicate rates of approximately 50 to 70% in the pediatric population and around 35% in adults. ^{3 – 5}

DIC signifies the breakdown of normal hemostatic mechanisms, potentially leading to organ dysfunction due to microthrombi-induced infarction, ultimately increasing mortality rates. Despite developing two validated diagnostic scoring systems for DIC in adults, a clear consensus needs to be provided in both adult and pediatric populations. Recognizing these challenges, a recent study in adults endeavored to formulate a simplified set of criteria to diagnose sepsis-associated coagulopathy (SAC), relying solely on platelet count and international normalized ratio (INR) values. ^{3 – 5} The INR, initially devised to monitor vitamin-K antagonist therapy, is assessed in this study as a proxy measure for the extent of coagulopathy. The severity of SAC, as determined by this approach, independently predicted in-hospital mortality in the Pediatric Intensive Care Unit (PICU). To our knowledge, no analogous investigations have yet been conducted within the pediatric septic shock cohort. ⁶

Sepsis presents a significant health challenge within the Pediatric Intensive Care Unit (PICU). The timeliness of treatment administered in the initial hours following the onset of sepsis can profoundly impact the patient’s outcome. The emergence of coagulopathy, which leads to unfavorable results, is a commonly observed phenomenon among patients affected by sepsis. While the overall mortality rate for patients afflicted by sepsis is declining, the incidence of sepsis and the subsequent deaths attributed to it are on an upward trajectory. ¹¹

Loberger JM et al. ¹² emphasized that a substantial portion of patients with positive blood cultures exhibited severe Sepsis-Associated Coagulopathy (SAC), and this disparity between the severe and non-severe groups was statistically significant. This implies a potential correlation between bacteremia and the development of SAC. This assertion is buttressed by various infectious manifestations, such as meningococcemia associated with purpura fulminans, one of the gravest indications of Disseminated Intravascular Coagulation (DIC). It should be noted that although most patients with Gram-negative bacteremia demonstrated severe SAC, the sample size remains insufficient to formulate definitive conclusions. The production of endotoxins by numerous Gram-negative bacteria is pivotal to the inception of DIC, being instrumental in initiating thrombin generation, a pivotal step in this process.

El-Nawawy AA et al. ¹² conducted a study focused on evaluating the impact of early hemostatic intervention on disseminated intravascular coagulopathy in patients contending with severe sepsis/septic shock. The investigation centered on patients admitted to the ICU prior to the clear manifestation of disseminated intravascular coagulopathy. Among the cohort of 80 patients included in this study, all of whom were at the subclinical stage of disseminated intravascular coagulopathy in conjunction with severe sepsis/septic shock, a random allocation was performed, dividing them into two distinct groups designated as group 1 and group 2. The outcomes revealed a noteworthy rise in mortality rates within group 2. Furthermore, the progression toward evident disseminated intravascular coagulopathy was significantly more frequent among patients in group 2 when contrasted with their counterparts in group 1 (45% versus 10%, respectively) (p<0.0001).

Lindell RB et al. ¹³ pointed out that precise identification of children afflicted by severe sepsis and septic shock in the Virtual Pediatric Systems database requires specific diagnostic codes designed for these specific conditions. The accuracy of these codes and the depth of clinical detail provided by the database establish a solid foundation for conducting sophisticated epidemiological studies on pediatric severe sepsis and septic shock within this extensive multicenter repository.

Ren C et al. ¹⁴ conducted an in-depth investigation into the potential predictive role of sepsis-associated coagulopathy (SAC) in relation to the clinical outcomes of critically ill patients contending with postoperative sepsis. Their research revealed that among the 175 patients enrolled in the study within the ICU setting, 41.1% (72 patients) exhibited the presence of SAC. Notably, the subset of patients affected by SAC demonstrated notably higher rates of in-hospital mortality in comparison to those without SAC (37.5% versus 11.7%; p<0.001). The results of both univariate and multivariate regression analyses substantiated a significant correlation between the existence of SAC and the heightened in-hospital mortality observed in sepsis patients specifically within surgical intensive care units, with a calculated hazard ratio (HR) of 3.75 and a 95% confidence interval (CI) ranging from 1.90 to 7.40 (p<0.001).

Weiss SL ² reported that among 6,925 screened patients, the prevalence of severe sepsis stood at 8.2% (95% confidence interval 7.6-8.9%). The primary sites of infection were the respiratory tract (40%) and the bloodstream (19%). Standard therapeutic measures encompassed mechanical ventilation (74% of patients), vasoactive drug infusions (55%), and corticosteroid administration (45%). The in-hospital mortality rate was recorded at 25% and exhibited no variance based on age or the distinction between developed and resource-constrained nations. At the juncture of sepsis detection, 67% of patients presented with multiple organ failure, with 30% subsequently experiencing the emergence or progression of multiple organ failure.

Loberger JM ¹² introduced a straightforward classification scheme for gauging the severity of SAC in PICU patients within 48 hours of admission, employing platelet counts and International Normalized Ratios (INRs). Crucial parameters, such as positive blood cultures and the duration of ventilator use, were incorporated into this framework to yield predictive insights. Interleukins are central to the immune system and play a pivotal role in a spectrum of immunological, inflammatory, and infectious conditions, including sepsis syndrome. The levels of interleukins are correlated with overall survival. They may wield direct or indirect influence over certain regulators of coagulation and fibrinolysis, potentially disrupting the delicate balance of hemostasis and thrombosis. ¹³

The early detection and proactive resuscitation of neonatal septic shock by community physicians can serve as a lifesaving measure. Valerani E et al. ¹⁴ concluded that SAC was associated with elevated 28-day mortality rates among sepsis patients. The administration of recombinant human soluble thrombomodulin (rhsTM) demonstrated a reduction in 28-day mortality, specifically among patients afflicted by SAC, as opposed to those lacking SAC.